| Value | ₹0.05 Cr |
|---|
BSE filing, NSE: FCL. Summary written from the filing by ALFA Finder's alert engine.
Fineotex Chemical Ltd: key numbers
- Share price
- ₹50.01
- Market cap
- ₹5,824 Cr
- Revenue (annual)
- ₹772.2 Cr
- Net profit (annual)
- ₹108.8 Cr
- P/E (TTM)
- 47.6×Sector 34.1×
- Promoter holding
- 62.30%+0.00% QoQ
- FII holding
- 2.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fineotex Chemical Ltd
All →Fineotex Chemical Merger & Restructuring
Fineotex Chemical's FZE subsidiary incorporated Fineotex America Inc. in Delaware, USA. The entity will supply water treatment chemicals for data centers and semiconductors.
Fineotex Chemical Annual General Meeting
Fineotex Chemical Limited conducted its 23rd Annual General Meeting on September 11, 2026. Shareholders discussed ordinary and special business items, including dividend and fund raising proposals.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new wholly-owned subsidiary, Fineotex Holdings Inc., in the USA for specialty chemical business activities.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical Limited incorporated a new wholly-owned step-down subsidiary, Fineotex Holdings Inc., in the USA. This entity will pursue specialty chemical and growth opportunities.
Fineotex Chemical Credit Rating
Fineotex Chemical Limited announced an upgrade in its long-term credit rating to [ICRA]AA- (Stable) by ICRA, while reaffirming its short-term rating at [ICRA]A1+.
Fineotex Chemical Business Update
Fineotex Chemical Ltd has filed its Business Responsibility and Sustainability Report for the financial year 2025-26, as mandated by SEBI regulations for listed entities.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr